MedTrace Logo

Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics

NCT02185209 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2022-08-18

No results posted yet for this study

Summary

The purpose of this study is to investigate if the use of systemic adjunctive antibiotics in the treatment of periimplantitis is needed.

Conditions

  • Periodontal Diseases
  • Periimplantitis

Interventions

DRUG

Placebo

Place capsule to mimic antibiotics

DRUG

Amoxicillin Sandoz

Tablet 500 mg amoxicillin Sandoz three times a day

DRUG

Metronidazole Sanofi

400 mg metronidazole Sanofi administered three times a day (TID)

DRUG

Phenoxymethylpenicillin Meda

1600 mg phenoxymethylpenicillin Meda, three time a day (TID)

Sponsors & Collaborators

  • Margareta Hultin

    lead OTHER

Principal Investigators

  • Margareta Hultin, DDSass. prof · Karolinska Institute, Dental medicine

  • Bodil Lund, DDSass.prof · Karolinska Institute, Dental Medicine

  • Dalia Kahlil, DDS, PhDstud · Karolinska Institute, Dental Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2022-05-27
Completion
2022-05-27

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185209 on ClinicalTrials.gov